Faster Generics Approval Could Cut Drug Costs, Senate Told
Health care professionals told a U.S. Senate committee Wednesday that faster approval of generic drugs would be an effective strategy to combat companies that buy off-patent drugs and jack up the...To view the full article, register now.
Already a subscriber? Click here to view full article